NCT07173062View on ClinicalTrials.gov

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 11, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
StrokeCoronary Arterial Disease (CAD)Myocardial Infarction (MI)Diabetes MellitusPeripheral Artery Disease (PAD)Chronic Kidney Disease(CKD)Albuminuria
Interventions
DIETARY_SUPPLEMENT

Spirulina Arthrospira platensis (microalgae)

Spirulina Arthrospira platensis (4 x \~500mg), taken twice daily as 2 capsules in the morning + 2 capsules in the evening

DIETARY_SUPPLEMENT

Gelidium corneum

Gelidium corneum (4 x \~500mg), taken twice daily as 2 capsules in the morning + 2 capsules in the evening

OTHER

Placebo

Microcrystalline cellulose, silicon dioxide and dicalcium phosphate (4 x \~500mg), taken twice daily as 2 capsules in the morning + 2 capsules in the evening

Trial Locations (1)

4200-319

RECRUITING

Unidade Local de Saúde de São João, Porto

All Listed Sponsors
collaborator

Centro Hospitalar De São João, E.P.E.

OTHER

lead

Universidade do Porto

OTHER